{
    "title": "113_hr4701",
    "content": "The Tick-Borne Disease Research Accountability and Transparency Act of 2014, also known as the Lyme Disease and Other Tick-Borne Diseases Act, amends the Public Health Service Act to require the Secretary to conduct or support research on Lyme disease and other tick-borne diseases. Biennial reports must include information on the progress made in improving outcomes for these diseases. The Tick-Borne Disease Research Accountability and Transparency Act of 2014 establishes a working group to conduct or support research on Lyme disease and other tick-borne diseases. The Secretary will establish the Interagency Lyme and Tick-Borne Disease Working Group to coordinate efforts, minimize overlap, and prioritize research on Lyme disease and other tick-borne diseases. The Working Group will provide updates on research every 24 months. The Interagency Lyme and Tick-Borne Disease Working Group will focus on research updates, engagement with participants, monitoring federal activities, and making recommendations to the Secretary for improvements. The Interagency Lyme and Tick-Borne Disease Working Group will hold annual public meetings to address scientific advances, research questions, surveillance activities, and emerging strains in pathogenic organisms. The Working Group consists of 14 members, including representatives from various federal agencies. The Interagency Lyme and Tick-Borne Disease Working Group consists of 14 members, including representatives from federal agencies and non-federal public members from various categories such as physicians, scientists, patients, and nonprofit organizations. The Interagency Lyme and Tick-Borne Disease Working Group includes 14 members from federal agencies and non-federal public members appointed by the Secretary, Speaker of the House, and Majority Leader of the Senate. Nonprofit organizations advocating for patients and individuals with beneficial expertise can also be part of the Working Group. The non-Federal public members of the Interagency Lyme and Tick-Borne Disease Working Group are appointed to ensure diversity of scientific perspectives, serve 4-year terms, meet as needed but at least twice a year, and submit reports on activities every 24 months. The Working Group is subject to the Federal Advisory Committee Act. The Interagency Lyme and Tick-Borne Disease Working Group must submit reports on its activities, including recommendations, to the Secretary and relevant congressional committees. Reports must be made publicly available on the Department of Health and Human Services website, and minority views can be included. \"SEC. 399OO-2. STRATEGIC PLAN.\" The Secretary must submit a strategic plan to Congress every 3 years, with details on Lyme disease and tick-borne disease research, budget requirements, improving outcomes, diagnosis, treatment, prevention, and progress benchmarks. The Secretary must submit a strategic plan to Congress every 3 years, including details on Lyme disease and tick-borne disease research, budget requirements, improving outcomes, diagnosis, treatment, prevention, and progress benchmarks. Additionally, relevant information developed by the Working Group will be shared with the public, including health care providers, public health departments, and other medical groups. No additional funds are authorized for this Act and its amendment, using existing available amounts. Passed by the House of Representatives on September 9, 2014."
}